357 results on '"Castaño G"'
Search Results
52. IN VIVO DOWN REGULATION OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION AFTER HEPATITIS C SUPERINFECTION
53. COEVOLUTION OF HYPERVARIABLE REGIONS OF HIV AND HCV IN A HIV PATIENT SUPERINFECTED WITH HEPATITIS C VIRUS
54. LATE PORTAL VEIN COMPLICATIONS AFTER LIVER TRANS-PLANTATION IN ADULTS
55. STUDY OF THE EFFECTS OF RIBAVIRIN ON CYTOKINE PRODUCTION OF RECALL ANTIGEN AND PHA-STIMULATED PERIFHERAL MONONUCLEAR CELLS (PBMC)
56. Detection of hepatitis G virus RNA in patients with acute non-A-E hepatitis
57. INFLUENCIA FISCAL SOBRE LA CONTABILIDAD EN COLOMBIA
58. Small Bowel Bacterial Overgrowth in Patients with Alcoholic Cirrhosis
59. Liver mitochondrial DNA damage and genetic variability of Cytochrome b – a key component of the respirasome – drive the severity of fatty liver disease.
60. Impaired quality of life after chikungunya virus infection: a 2-year follow-up study of its chronic inflammatory rheumatism in La Virginia, Risaralda, Colombia
61. Depression and anxiety screening using Zung Self-Rating Scales (SDS/SAS) among patients with post-Chikungunya chronic inflammatory rheumatism: a comparative study of a 2-year follow-up cohort in La Virginia, Risaralda, Colombia
62. Baseline risk factors associated with the development of One and Two Years post-Chikungunya chronic inflammatory rheumatism, La Virginia, Risaralda, Colombia, 2015-2017
63. Subacute disease (3-to-11 weeks) predicts post-Chikungunya chronic inflammatory rheumatism (>12 weeks): Findings of an ambispective cohort in La Virginia, Risaralda, Colombia
64. Neutrophil CD64 expression, procalcitonin and presepsin are useful to differentiate infections from flares in SLE patients with SIRS
65. AB0498 Soluble CD14 (PRESEPSIN) as a potential biomarker to discriminate infection vs. activity in patients with systemic lupus erythematosus
66. REVISIÓN DE MODELOS DE FRACTURAMIENTO Y CONTROLES ESTRUCTURALES COMO GUIAS DE EXPLORACIÓN DE FILONES AURÍFEROS EN EL DISTRITO MINERO SEGOVIA REMEDIOS
67. Capítulo 15 - Enfermedades del páncreas
68. Identificación De Factores De Riesgo Y Riesgos Asociados En El Proceso De Pasterización Y Envasado Industrial De Leche Durante El Año 2014 En Colombia
69. Mendelian randomisation suggests no beneficial effect of moderate alcohol consumption on the severity of nonalcoholic fatty liver disease
70. La dieta como factor de riesgo de hipovitaminosis D en la población pediátrica española
71. Capítulo 26 - Enfermedades del páncreas
72. INFLUENCIA FISCAL SOBRE LA CONTABILIDAD EN COLOMBIA
73. Use of whey and molasses as additive for producing silage of Cuba OM-22 (Cenchrus purpureus x Cenchrus glaucum).
74. Detección de puntas epilépticas en señales EEG usando wavelets y redes neuronales
75. RESULTADOS Y APRENDIZAJE EN UN CURSO PRÁCTICO DE ECOENDOSCOPIA TERAPÉUTICA EN MODELO ANIMAL PORCINO
76. Síntesis de pironas con posible actividad leishmanicida
77. Síntesis de pironas con posible actividad leishmanicida.
78. Evaluación de estados financieros y diseño de un presupuesto de construcción de 30 viviendas aplicados en la constructora Mavi Ltda, y análisis de un contrato de Leaseback
79. Differentiation of autoimmune pancreatitis from pancreas cancer: utility of anti-amylase and anti-carbonic anhydrase II autoantibodies
80. The influence of common gene variants of the xenobiotic receptor(PXR)in genetic susceptibility to intrahepatic cholestasis of pregnancy
81. Influencia fiscal sobre la contabilidad en Colombia
82. Th-P16:325 A comparison of the effects of D-003 and policosanol (5 and 10 mg/d) in patients with type II hypercholesterolemia: A randomized, double-blinded study
83. Sedación en endoscopia digestiva
84. Hipercalcemia y disfonía por adenoma gigante de paratiroides
85. Pancreatitis autoinmune. ¿Una entidad poco frecuente o infradiagnosticada? Características anatomopatológicas, clínicas e inmunológicas
86. Consumo de heroína en Colombia
87. Factores pronósticos de la pancreatitis aguda
88. Cocaínas fumables en Latinoamérica
89. Comparison of diagnostic categories in the Asturian (Spain) population according to 1997 ADA and 1985 WHO diagnostic criteria
90. Prevalence of diabetes mellitus type 2 in Asturias (Spain)
91. Effect of policosanol in older patients with type II hypercholesterolemia and high coronary risk
92. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients
93. Comparative study of the efficacy and tolerability of policosanol (10 mg/d and lovastatin (20 mg/d) on patients with type ii hypercholesterolemia and non insulin dependent diabetes mellitus
94. Efficacy of 3 MU vs. 5 MU of interferon alpha induction therapy innaive patients with chronic hepatitis C
95. Effects of vasoactive drugs on arterial compliance in cirrhoticpatients
96. Effects of policosanol on postmenopausal women with type II hypercholesterolemia
97. A one year open study on the efficacy, and tolerability of policosanol (20 mg/day) in patients with hypercholesterolemia and high global coronary risk
98. Effects of policosanol on postmenopausal women with type II hypercholesterolemia
99. A comparative study on the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and high coronary risk
100. 2.P.61 Comparative study of policosanol, gemfibrozil and combination therapy in the treatment of type II hypercholesterolemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.